Navigation Links
BioCryst Provides Update Regarding Peramivir for Influenza
Date:9/30/2009

BIRMINGHAM, Ala., Sept. 30 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has delivered a written response to the request for proposal (RFP) announced on September 21, 2009 from the U.S. Department of Health & Human Services (HHS) for the supply of intravenous (i.v) peramivir for the treatment of critically ill influenza patients under Emergency Use Authorization (EUA). BioCryst management intends to provide an update once the RFP process has reached a conclusion.

In addition, BioCryst announced it is initiating two Phase 3 studies of i.v. peramivir for the treatment of hospitalized patients with serious influenza. These studies are intended to support U.S. regulatory approval of peramivir as a treatment for influenza. Expenses for these Phase 3 studies are covered under the recently modified $180 million HHS/Biomedical Advanced Research and Development Authority (BARDA) contract to develop peramivir for the treatment of influenza.

"The novel H1N1 2009 virus is already producing significant morbidity and mortality within North America, and I expect the burden on the healthcare system to increase in the coming weeks," said Michael Ison, M.D. MS, Assistant Professor at Northwestern University Feinberg School of Medicine and lead investigator for one of the studies. "This Phase 3 study will provide an important opportunity to evaluate peramivir in an area of unmet medical need for seriously ill patients in the hospital setting."

According to the U.S. Centers for Disease Control & Prevention (CDC), on average 5 to 20 percent of the population gets the flu in the U.S.; more than 200,000 people are hospitalized from flu complications and about 36,000 people die from flu-related causes.

"BioCryst is pleased to be able to proceed with the first phase 3 studies of an anti-viral agent ever conducted in influenza patients requiring hospitalization," said Dr. Willi
'/>"/>

SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza
2. BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results
3. BioCryst Pharmaceuticals to Announce Peramivir Update and First Quarter 2009 Financial Results on May 8, 2009
4. BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting
5. BioCryst Announces Initiation of Phase II Study of Intramuscular Peramivir for the Treatment of Seasonal Influenza
6. BioCryst Updates Peramivir Clinical Development Plan
7. BioCryst Provides Forodesine HCl Update
8. BioCryst Initiates Enrollment in Pivotal Trial of Forodesine HCL in Patients with Cutaneous T-Cell Lymphoma (CTCL)
9. New Large-Scale, Global Study Provides Additional Information About an Intensified Dose-Regimen of PLAVIX(R) in Acute Coronary Syndrome Patients Undergoing Angioplasty
10. Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program
11. Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on Interactions With FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... -- BGI a annoncé aujourd,hui que son laboratoire ... à Hong Kong avait ...  (Collège des pathologistes américains, ou CAP). Les installations ... constituent le premier laboratoire clinique de séquençage ... CAP en Chine, car il satisfait les normes ...
(Date:7/2/2015)... 2, 2015  New product launches are critical events ... in educating thought leaders about new products, Medical Affairs ... how well a new therapy performs at launch. ... and consulting leader Best Practices, LLC, critical aspects of ... on are early stage thought leader (TL) interaction, successful ...
(Date:7/2/2015)... 2, 2015 Roche,s Bloodhound technology is ... segment in hematology testing, according to Kalorama Information.  ... unveiling of its Bloodhound digital cell imaging technology ... 511 hematology analyzer – is notable as ... by current leader CellaVision, but also compete more ...
Breaking Medicine Technology:BGI obtient la certification du Collège des pathologistes américains (CAP) 2Medical Affairs Role in Thought Leader Education is Key Success Factor for New Product Launches in the Pharmaceutical Industry 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 3
... today visited the future site of Endo Pharmaceutical,s corporate headquarters ... continued commitment to the region and its plans to create ... Pennsylvania we are employing the kind of creative cooperation that ... ribbon on a new headquarters," said Corbett. "This investment in ...
... FISHKILL, N.Y., Jan. 17, 2012  Nano Mask, Inc. (NMI) (Pink ... company focused on emergency and critical care as well as ... sales, marketing and distribution office in Riyadh, Saudi Arabia to ... into the strong demand for its products in the region. ...
Cached Medicine Technology:Nano Mask Opens Office in Riyadh, Saudi Arabia Due to Strong Demand for Company's Products 2
(Date:7/3/2015)... , ... July 04, 2015 , ... The Harvest Hope Food Bank will ... Four local AlignLife offices in the area of Greenville SC are making it ... be made by patients only. They are asking for donations from the public as well. ...
(Date:7/3/2015)... ... 03, 2015 , ... Renowned rhinoplasty surgeon and Symposium Chairman, ... Rhinoplasty Symposium . To be held from March 4th - 6th, the 2016 (a ... Westin Galleria Dallas. , Designed to take participants from the basic training and fundamentals ...
(Date:7/3/2015)... ... July 03, 2015 , ... Talcum powder attorneys representing clients in ... Talcum Powder Cancer Lawsuit Center website. Just as the previous version did, the new ... offering timely lawsuit updates and ovarian cancer warning information. The site is routinely updated ...
(Date:7/3/2015)... ... July 03, 2015 , ... Every year, One-to-1 Fitness and the ... members of the Red Deer community with free fitness training and indoor fitness boot ... food, events and entertainment raised thousands of charity dollars and ended with a $10,000 ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... Following the ... stated the number of obese Americans outnumber merely overweight Americans, Samir Becic emphatically declared ... biggest threats to American society right now," Becic said. "We must understand the magnitude ...
Breaking Medicine News(10 mins):Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 2Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 3Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 3Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 4
... -- A new analysis confirms that those who take the ... and die than those who take a similar type of ... considerable," the analysis authors wrote. Avandia (rosiglitazone) helps control ... patients with type 2 diabetes. Studies in recent years have ...
... March 16 (HealthDay News) -- Tooting another,s horn may ... school,s band, a new study suggests. Researchers tested ... found they were heavily contaminated with different kinds of ... minor to serious infections and allergic diseases. The ...
... 17, 2011 -- The increase in the number of ... is a positive sign toward easing the primary care ... (ACP), the nation,s second-largest doctors group. The 2011 ... 8.0 percent increase from last year, with 2,940 U.S. ...
... (HealthDay News) -- Many American children who qualify for ... because their parents are confused about enrollment and eligibility, ... in 10,175 low-income households in Oregon and found that ... Stamp Program were not enrolled in the Oregon Health ...
... Texas A&M University and Texas State University found that ... likely to eat their veggies. The report, published in ... adults aged 50+ and includes recommendations for promoting gardening ... Aime Sommerfeld, Amy McFarland, Tina Waliczek, and Jayne Zajicek, ...
... that could help them track how effectively the immune system ... forms the plaques considered one of the hallmarks of Alzheimer,s ... the Journal of Alzheimer,s Disease , demonstrates how the ... is expressed differently in different Alzheimer,s patients. The finding may ...
Cached Medicine News:Health News:Analysis Confirms Avandia May Harm the Heart 2Health News:Residency match results encouraging for adults needing primary care 2Health News:Parents Often Confused About Kids' Health Coverage 2Health News:Gardening linked to increased vegetable consumption in older adults 2Health News:Scientists ID possible biomarker to gauge Alzheimer's prognosis, effect of therapies 2Health News:Scientists ID possible biomarker to gauge Alzheimer's prognosis, effect of therapies 3Health News:Scientists ID possible biomarker to gauge Alzheimer's prognosis, effect of therapies 4
Cruciate Retaining, Posterior Stabilized and Constrained Components....
... posterior stabilized knee has an advanced ... flange mates with both resurfacing and ... precise, repeatable kinematics and fit with ... reduce wear. Constant cutting guide peg ...
... system is a long term, ... clinically proven design. Available in ... correct cruciate retaining configurations. In ... of identification keeps the user ...
... System was designed to replicate normal ... has a recessed, deepened and extended ... the patella, which has been shown ... groove promotes more normal kinematics and ...
Medicine Products: